China Pharma Holdings (CPHI) Cash from Operations (2010 - 2026)
China Pharma Holdings (CPHI) reported Cash from Operations of 55292.0 for Q1 2026, up 24.95% on a YoY basis from 44250.42 in Q1 2025, and down 136.38% quarter-over-quarter from 151990.0 in Q4 2025.
China Pharma Holdings (CPHI) Cash from Operations (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Cash from Operations for 17 years, with the latest figure at 55292.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 24.95% year-over-year to 55292.0; the trailing twelve-month figure through Mar 2026 stood at 166645.0 (up 58.08% YoY), and the FY2025 full-year result was 148261.0, up 136.51% from the prior year.
- Cash from Operations for Q1 2026 stood at 55292.0, down from 151990.0 in the prior quarter.
- The five-year high for Cash from Operations was 1007286.0 in Q3 2023, with the low at 1468214.0 in Q1 2023.
- Historically, Cash from Operations has averaged 83666.18 across 5 years, with a median of 55292.0 in 2026.
- Annual changes were most pronounced in 2024 — Cash from Operations soared 1438.41% — and 2025, when it tumbled 404.74%.
- China Pharma Holdings' Cash from Operations stood at 584594.0 in 2022, then tumbled by 103.82% to 22323.0 in 2023, then soared by 1438.41% to 298773.0 in 2024, then tumbled by 49.13% to 151990.0 in 2025, then sank by 136.38% to 55292.0 in 2026.
- The last three Cash from Operations figures came in at 55292.0 (Q1 2026), 151990.0 (Q4 2025), and 236987.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 125.13 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 89.36 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -55,292.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55,292.00 |
| Mar 31, 2026 | -55,292.00 |
| Dec 31, 2025 | 151,990.00 |
| Dec 31, 2025 | 151,990.00 |
| Sep 30, 2025 | -236,987.00 |
| Sep 30, 2025 | -236,987.00 |
| Jun 30, 2025 | 306,934.00 |
| Jun 30, 2025 | 306,934.00 |
| Mar 31, 2025 | -73,676.00 |
| Mar 31, 2025 | -73,676.00 |
| Dec 31, 2024 | 298,773.00 |
| Dec 31, 2024 | 298,773.00 |
| Sep 30, 2024 | -46,952.00 |
| Sep 30, 2024 | -46,952.00 |
| Jun 30, 2024 | -72,726.00 |
| Jun 30, 2024 | -72,726.00 |
| Mar 31, 2024 | -585,158.00 |
| Mar 31, 2024 | -585,158.00 |
| Dec 31, 2023 | -22,323.00 |
| Dec 31, 2023 | -22,323.00 |